|
1
|
Stewart BW and Wild CP: World cancer
report 2014. lyon cedex. France: The international agency for
research on cancer;
|
|
2
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W,
Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in
high-risk areas of China: Research progress and challenges. Ann
Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu L, Gu C, Zhong D, Shi L, Kong Y, Zhou Z
and Liu S: Induction of autophagy counteracts the anticancer effect
of cisplatin in human esophageal cancer cells with acquired drug
resistance. Cancer Lett. 355:34–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang XJ, Chen S, Huang KX and Le WD: Why
should autophagic flux be assessed? Acta Pharmacol Sin. 34:595–599.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng X, Gong F, Chen Y, Jiang Y, Liu J, Yu
M, Zhang S, Wang M, Xiao G and Liao H: Autophagy promotes
paclitaxel resistance of cervical cancer cells: Involvement of
Warburg effect activated hypoxia-induced factor 1-α-mediated
signaling. Cell Death Dis. 5:e13672014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
ODonovan TR, OSullivan GC and McKenna SL:
Induction of autophagy by drug-resistant esophageal cancer cells
promotes their survival and recovery following treatment with
chemotherapeutics. Autophagy. 7:509–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Solomon VR and Lee H: Chloroquine and its
analogs: A new promise of an old drug for effective and safe
cancertherapies. Eur J Pharmacol. 625:220–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rabinowitz JD and White E: Autophagy and
metabolism. Science. 330:1344–1348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zanotto-Filho A, Braganhol E, Klafke K,
Figueiró F, Terra SR, Paludo FJ, Morrone M, Bristot IJ, Battastini
AM, Forcelini CM, et al: Autophagy inhibition improves the efficacy
of curcumin/temozolomide combination therapy in glioblastomas.
Cancer Lett. 358:220–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Golden EB, Cho HY, Jahanian A, Hofman FM,
Louie SG, Schönthal AH and Chen TC: Chloroquine enhances
temozolomide cytotoxicity in malignant gliomas by blocking
autophagy. Neurosurg Focus. 37:E122014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu
C, Liu X and Li W: Synergistic anti-tumour effects of tetrandrine
and chloroquine combination therapy in human cancer: A potential
antagonistic role for p21. Br J Pharmacol. 172:2232–2245. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lefort S, Joffre C, Kieffer Y, Givel AM,
Bourachot B, Zago G, Bieche I, Dubois T, Meseure D, Vincent-Salomon
A, et al: Inhibition of autophagy as a new means of improving
chemotherapy efficiency in high-LC3B triple-negative breast
cancers. Autophagy. 10:2122–2142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farrow JM, Yang JC and Evans CP: Autophagy
as a modulator and target in prostate cancer. Nat Rev Urol.
11:508–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang A and Kimmelman AC: Inhibition of
autophagy attenuates pancreatic cancer growth independent of
TP53/TRP53 status. Autophagy. 10:1683–1684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
White E, Mehnert JM and Chan CS:
Autophagy, metabolism, and cancer. Clin Cancer Res. 21:5037–5046.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizushima N, Yoshimori T and Levine B:
Methods in mammalian autophagy research. Cell. 140:313–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rustgi AK and El-Serag HB: Esophageal
carcinoma. N Engl J Med. 371:2499–2509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
DiMasi JA, Hansen RW and Grabowski HG: The
price of innovation: New estimates of drug development costs. J
Health Econ. 22:151–185. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu S and Li X: Autophagy inhibition
enhances sensitivity of endometrial carcinoma cells to paclitaxel.
Int J Oncol. 46:2399–2408. 2015.PubMed/NCBI
|
|
22
|
Balic A, Sørensen MD, Trabulo SM, Sainz B
Jr, Cioffi M, Vieira CR, Miranda-Lorenzo I, Hidalgo M, Kleeff J,
Erkan M and Heeschen C: Chloroquine targets pancreatic cancer stem
cells via inhibition of CXCR4 and hedgehog signaling. Mol Cancer
Ther. 13:1758–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan C, Wang W, Zhao B, Zhang S and Miao J:
Chloroquine inhibits cell growth and induces cell death in A549
lung cancer cells. Bioorg Med Chem. 14:3218–3222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang L, Gao C, Yao S and Xie B: Blocking
autophagic flux enhances matrine-induced apoptosis in human
hepatoma cells. Int J Mol Sci. 14:23212–23230. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie X, White EP and Mehnert JM: Coordinate
autophagy and mTOR pathway inhibition enhances cell death in
melanoma. PLoS One. 8:e550962013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan QW, Cheng C, Hackett C, Feldman M,
Houseman BT, Nicolaides T, Haas-Kogan D, James CD, Oakes SA,
Debnath J, et al: Akt and autophagy cooperate to promote survival
of drug-resistant glioma. Sci Signal. 3:ra812010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Q, Luo XY, Jiang H, Yang MH, Yuan GH,
Tang Z and Wang H: Hydroxychloroquine facilitates autophagosome
formation but not degradation to suppress the proliferation of
cervical cancer SiHa cells. Oncol Lett. 7:1057–1062.
2014.PubMed/NCBI
|
